| Patient | Clara Barton |
|---|---|
| Date of birth | 1973-12-25 |
| Identifiers | MRN HR-NI024-SYN; SSN (made up) 000-24-3357 |
| Document date | 2026-06-16 |
| Author | Eleanor Whitcombe, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Five-month depression review in continuation treatment. [S]
Ms. Barton returns two months after her twelve-week review. The care manager's telephone PHQ-9 planned for about four weeks after that review was not completed: two calls in May went unanswered while she was at a week-long training course, and no further call was booked. She feels like herself again, with steady energy, and sleeps about seven hours. She has finished fifteen of sixteen CBT sessions and has joined the monthly peer support group. She works about 45 hours a week, walks most days, and sees friends weekly. She takes sertraline 100 mg every morning, has missed no doses, and has no side effects. She has had no suicidal thoughts. [S]
| Element | Detail |
|---|---|
| Interval change | Feels like herself; steady energy |
| Missed contact | Telephone PHQ-9 planned in May not completed |
| Sleep | About seven hours |
| Psychotherapy | Fifteen of sixteen CBT sessions; monthly peer support group |
| Safety | No suicidal thoughts |
| PHQ-9 | 4 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy normal; weight back to her usual |
| Gastrointestinal | Negative | No nausea or bleeding |
| Psychiatric | Negative | Mood good; no suicidal thoughts, elevated mood, or racing thoughts |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 2026-01-20 to 2026-03-03 | completed | S |
| Sertraline 100 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 2026-03-03 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-16 | Body height | 152 | cm | S |
| 2026-06-16 | Body weight | 51.6 | kg | S |
| 2026-06-16 | Body mass index (BMI) [Ratio] | 22.3 | kg/m2 | S |
| 2026-06-16 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-06-16 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-06-16 | Heart rate | 70 | /min | S |
| 2026-06-16 | Respiratory rate | 14 | /min | S |
| 2026-06-16 | Body temperature | 36.7 | Cel | S |
| 2026-06-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S |
Vital signs recorded on 2026-06-16; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well, brisk, and cheerful |
| Mental status | Alert; mood "like myself"; affect full and reactive; thought process linear; no suicidal ideation; insight and judgment good |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Major depressive disorder, recurrent, moderate (moderately severe symptoms at intake), after a prolonged humanitarian deployment; synthetic modern diagnosis linked to her documented periods of depression and nervous prostration | active | confirmed | F33.1 | S — Synthetic modern diagnosis. Her periods of depression and nervous prostration are documented in her own words (D); calling them major depression is a retrospective interpretation (R), and no diagnosis was made in her lifetime. |
| Occupational burnout after eighteen months leading field medical relief in a war zone | active | confirmed | Z73.0 | S — Synthetic contributing factor echoing her documented exhaustion after wartime relief work; burnout is an occupational phenomenon, not a mental disorder. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 | Baseline, then at least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 4: remission |
| Survey | Monthly PHQ-9 between the twelve-week review and today | At least monthly during acute treatment | Deferred | Not done, a deviation from the protocol: the care-manager telephone PHQ-9 planned for about four weeks after the twelve-week review was not completed after two unanswered calls, leaving nine weeks unmeasured. No harm resulted judging by today's review: she reached remission and had no suicidal thoughts. Corrective action: the registry now books a callback within a week after any unanswered call and alerts Dr. Whitcombe if a scheduled score is missing |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit during active treatment | Completed today | No suicidal thoughts, intent, plan, or behavior since the last visit; PHQ-9 item 9 scored 0. Protective factors stronger than at intake. Safety plan reviewed |
| Medication safety | Adherence and adverse-effect review | Every visit during active treatment | Completed today | No missed doses; no side effects |
| Self-management | Psychotherapy, sleep, work hours, and social contact | Every visit during active treatment | Completed today | Fifteen of sixteen CBT sessions; sleep about seven hours; 45-hour week; monthly peer support group |
| Laboratory | Lithium, anticonvulsant, or antipsychotic monitoring (levels, metabolic tests, AIMS) | Only on those drugs | Not indicated | Treated with an SSRI only |
Goal progress:
Guideline basis: VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)
Follow-up: PHQ-9 in two to three months; preventive visit in October. Next scheduled visit 2026-10-13: periodic adult preventive visit. [S]